MarketPeel
Insider Trading Intelligence
BL

Bain Capital Life Sciences Investors, Llc

OLMA
10% OWNER · OLEMA PHARMACEUTICALS, INC. · CIK 0001703031
FILING MIX · LIFETIME64%/36%
BUYS
30
SELLS
17
TOTAL VALUE
$248.06M
COMPANIES
10
ACTIVE SINCE
Feb 2020
HOLDINGS NOW
49,424,600
AVG SELL PX
$28.75
TRADE KIND
SHOWING 47 / 47
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
14 backtested trades · 8 horizons · 11 pending
Forward-return performance of every backtestable P/S trade by Bain Capital Life Sciences Investors, Llc, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d14+71.43%+2.48%+0.13%+2.36%+0.01%
14d14+71.43%+18.82%+0.71%+18.11%+9.77%
30d14+71.43%+14.53%-0.92%+17.11%+15.88%
60d14+50.00%-3.04%-4.35%+1.30%+7.87%
90d14(1 pending)+23.08%-14.01%-4.35%-9.66%-14.80%
180d14(2 pending)+25.00%-27.88%+1.00%-28.89%-22.68%
1y14(2 pending)+41.67%+15.30%+6.32%+8.97%-21.13%
2y14(6 pending)+12.50%-71.78%+16.17%-87.95%-92.85%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
OLMA · 4,300,000 shares · as of Jan 10, 2025
01,950,0003,900,0005,850,0007,800,000SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 30 buys / 17 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
RPID
RAPID MICRO BIOSYSTEMS, INC.
PURCHASE
1,463,0001,463,000May 20, 2026May 22, 2026View →
RPID
RAPID MICRO BIOSYSTEMS, INC.
PURCHASE
1,463,0001,463,000May 20, 2026May 22, 2026View →
RPID
RAPID MICRO BIOSYSTEMS, INC.
PURCHASE
1,463,0001,463,000May 20, 2026May 22, 2026View →
HTFL
HEARTFLOW, INC.
SALE
892,533$29.18$26.04M8,504,382Apr 30, 2026Apr 30, 2026View →
HTFL
HEARTFLOW, INC.
SALE
56,224$30.05$1.69M8,448,158Apr 30, 2026Apr 30, 2026View →
HTFL
HEARTFLOW, INC.
SALE
797,133$29.37$23.41M9,396,915Apr 29, 2026Apr 30, 2026View →
HTFL
HEARTFLOW, INC.
SALE
254,110$30.51$7.75M10,194,048Apr 28, 2026Apr 30, 2026View →
KLRA
KAILERA THERAPEUTICS, INC.
SALE
16,875,0000Apr 20, 2026Apr 20, 2026View →
KLRA
KAILERA THERAPEUTICS, INC.
PURCHASE
4,145,76821,020,768Apr 20, 2026Apr 20, 2026View →
KLRA
KAILERA THERAPEUTICS, INC.
SALE
4,145,7680Apr 20, 2026Apr 20, 2026View →
KLRA
KAILERA THERAPEUTICS, INC.
PURCHASE
1,562,500$16.00$25.00M22,583,268Apr 20, 2026Apr 20, 2026View →
KLRA
KAILERA THERAPEUTICS, INC.
PURCHASE
16,875,00016,875,000Apr 20, 2026Apr 20, 2026View →
HTFL
HEARTFLOW, INC.
SALE
2,000,000$28.05$56.10M10,448,158Feb 4, 2026Feb 6, 2026View →
HTFL
HEARTFLOW, INC.
SALE
0Aug 11, 2025Aug 13, 2025View →
HTFL
HEARTFLOW, INC.
SALE
35,081,5640Aug 11, 2025Aug 13, 2025View →
HTFL
HEARTFLOW, INC.
PURCHASE
433,924$15.20$6.60M12,448,158Aug 11, 2025Aug 13, 2025View →
HTFL
HEARTFLOW, INC.
PURCHASE
12,014,23412,014,234Aug 11, 2025Aug 13, 2025View →
SLDB
SOLID BIOSCIENCES INC.
PURCHASE
6,444,170$4.03$25.96M6,444,170Feb 19, 2025Feb 21, 2025View →
SLDB
SOLID BIOSCIENCES INC.
PURCHASE
1,000,000$4.03$4.03M5,034,582Feb 19, 2025Feb 21, 2025View →
OLMA
OLEMA PHARMACEUTICALS, INC.
PURCHASE
3,500,0003,500,000Jan 10, 2025Jan 13, 2025View →
OLMA
OLEMA PHARMACEUTICALS, INC.
SALE
3,500,0004,300,000Jan 10, 2025Jan 13, 2025View →
OLMA
OLEMA PHARMACEUTICALS, INC.
PURCHASE
300,000$5.76$1.73M7,800,000Jan 8, 2025Jan 13, 2025View →
NAMS
NEWAMSTERDAM PHARMA CO N.V.
PURCHASE
1,632,653$24.50$40.00M1,632,653Dec 13, 2024Dec 17, 2024View →
KYTX
KYVERNA THERAPEUTICS, INC.
PURCHASE
2,713,8682,713,868Feb 12, 2024Feb 14, 2024View →
KYTX
KYVERNA THERAPEUTICS, INC.
SALE
12,351,0870Feb 12, 2024Feb 14, 2024View →
KYTX
KYVERNA THERAPEUTICS, INC.
PURCHASE
450,000$22.00$9.90M3,163,868Feb 12, 2024Feb 14, 2024View →
SLDB
SOLID BIOSCIENCES INC.
PURCHASEGRANT
Stock grant
904,160$5.53$5.00M4,034,582Jan 11, 2024Jan 12, 2024View →
ANNX
ANNEXON, INC.
PURCHASE
300,000$2.13$639.7K5,701,926May 25, 2023May 30, 2023View →
XLO
XILIO THERAPEUTICS, INC.
PURCHASE
21,812$9.56$208.6K2,802,225Dec 10, 2021Dec 10, 2021View →
XLO
XILIO THERAPEUTICS, INC.
PURCHASE
3,188$10.24$32.6K2,805,413Dec 10, 2021Dec 10, 2021View →
XLO
XILIO THERAPEUTICS, INC.
PURCHASE
4,011$9.84$39.5K2,780,413Dec 9, 2021Dec 10, 2021View →
XLO
XILIO THERAPEUTICS, INC.
PURCHASE
13,458$9.62$129.5K2,776,402Dec 8, 2021Dec 10, 2021View →
RPID
RAPID MICRO BIOSYSTEMS, INC.
PURCHASE
100,000$20.00$2.00M8,434,560Jul 19, 2021Jul 21, 2021View →
RPID
RAPID MICRO BIOSYSTEMS, INC.
PURCHASE
1,334,5628,334,560Jul 19, 2021Jul 21, 2021View →
RPID
RAPID MICRO BIOSYSTEMS, INC.
SALE
6,672,8190Jul 19, 2021Jul 21, 2021View →
RPID
RAPID MICRO BIOSYSTEMS, INC.
PURCHASE
6,999,9986,999,998Jul 19, 2021Jul 21, 2021View →
RPID
RAPID MICRO BIOSYSTEMS, INC.
SALE
35,000,0010Jul 19, 2021Jul 21, 2021View →
ANNX
ANNEXON, INC.
PURCHASE
2,522,3852,522,385Jul 28, 2020Jul 28, 2020View →
ANNX
ANNEXON, INC.
SALE
2,812,5430Jul 28, 2020Jul 28, 2020View →
ANNX
ANNEXON, INC.
PURCHASE
400,000$17.00$6.80M3,241,628Jul 28, 2020Jul 28, 2020View →
ANNX
ANNEXON, INC.
PURCHASE
319,2432,841,628Jul 28, 2020Jul 28, 2020View →
ANNX
ANNEXON, INC.
SALE
22,222,2210Jul 28, 2020Jul 28, 2020View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
PURCHASE
2,825,6022,825,602Feb 4, 2020Feb 6, 2020View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
PURCHASE
294,117$17.00$5.00M3,979,292Feb 4, 2020Feb 6, 2020View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
PURCHASE
859,5733,685,175Feb 4, 2020Feb 6, 2020View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
SALE
2,825,6020Feb 4, 2020Feb 6, 2020View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
SALE
859,5730Feb 4, 2020Feb 6, 2020View →
Other insiders · OLMA
Loading peer insiders…
About this filer
CIK 0001703031
ROLE
10% Owner
PRIMARY
OLMA
COMPANIES
10
ACTIVE SINCE
Feb 2020
MARKETPEEL · /INSIDER/0001703031DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback